Evaluation of optimal initial dosage and international normalized ratio in patients receiving warfarin therapy in hospital
- At: 2010 FIP Congress in Lisbon (Portugal)
- Type: Poster
- By: LI, Wen-Chin (Tri-Service General Hospital, Taipei, China Taiwan)
- Co-author(s): Wang, Shiao-Ping (Tri-Service General Hospital, TAIPEI, China Taiwan)
Chin, Ya-Huei (Tri-Service General Hospital, TAIPEI, China Taiwan)
Chen, Jye-Daa (Tri-Service General Hospital, TAIPEI, China Taiwan)
Background: Warfarin is an anticoagulant agent for thromboembolism prevention, which therapeutic index is narrow. The major adverse effects of warfarin are bleeding and thromboembolism. The American College of Chest Physicians recommends a target INR range of 2-3 for most indications of warfarin. However, some studies indicated that genotypes are.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.